Setting

Global Diagnostic Specialty Antibodies Market 2020-2027 by Type (Monoclonal, Polyclonal, Others), Application (Oncology, Hepatitis, Infectious, Dengue), End User (Hospitals, Diagnostic Labs), and Region: Trend Outlook and Growth Opportunity

Published: 30 Jun 2021 | Report Code: 10248056 | Pages: 144

Global diagnostic specialty antibodies market will reach $28.97 billion by 2027, growing by 4.9% annually over 2020-2027 owing to the high number of patient pool undergoing diagnosis of HIV and growing demand for speciality diagnostics around the world, the advancements in DNA based technologies and diagnostics, and the increase in the prevalence of diseases such as infectious diseases, influenza and cancer. Highlighted with 79 tables and 70 figures, this 144-page report “Global Diagnostic Specialty Antibodies Market 2020-2027 by Type (Monoclonal, Polyclonal, Others), Application (Oncology, Hepatitis, Infectious, Dengue), End User (Hospitals, Diagnostic Labs), and Region: Trend Outlook and Growth Opportunity” is based on a comprehensive research of the entire global diagnostic specialty antibodies market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global diagnostic specialty antibodies market in every aspect of the classification from perspectives of Type, Application, End User, and Region. Based on Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Monoclonal Antibodies • Polyclonal Antibodies • Other Types Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Natural/Biological Products • Synthetic Products Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Oncology Diagnosis • Hepatitis Diagnosis • Infectious Disease Diagnosis • Dengue Diagnostics • Tuberculosis Diagnostics • HIV Diagnostics • Other Applications Based on End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Hospitals & Clinics • Diagnostic Laboratories • Other End Users Geographically, the following regions together with the listed national/local markets are fully investigated: • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • North America (U.S., Canada, and Mexico) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (UAE, Saudi Arabia, South Africa) For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2017-2027. The breakdown of all regional markets by country and split of key national markets by Type, Application, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Key Players (this may not be a complete list and extra companies can be added upon request): Abbott Laboratories Abcam plc Agilent Technologies, Inc. Aytu BioScience, Inc. Becton, Dickinson and Company Bio-Rad Laboratories, Inc. Boehringer Ingelheim International GmbH Creative Diagnostics Enzo Life Sciences, Inc. F. Hoffmann-La Roche AG Merck KGaA Polymun Scientific Immunbiologische Forschung GmbH Sanofi S.A. Sartorius AG Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents

1 Introduction	8
1.1 Industry Definition and Research Scope	8
1.1.1 Industry Definition	8
1.1.2 Research Scope	9
1.2 Research Methodology	12
1.2.1 Overview of Market Research Methodology	12
1.2.2 Market Assumption	13
1.2.3 Secondary Data	13
1.2.4 Primary Data	13
1.2.5 Data Filtration and Model Design	14
1.2.6 Market Size/Share Estimation	15
1.2.7 Research Limitations	16
1.3 Executive Summary	17
2 Market Overview and Dynamics	19
2.1 Market Size and Forecast	19
2.1.1 Impact of COVID-19 on World Economy	20
2.1.2 Impact of COVID-19 on the Market	22
2.2 Major Growth Drivers	24
2.3 Market Restraints and Challenges	27
2.4 Emerging Opportunities and Market Trends	30
2.5 Porter’s Fiver Forces Analysis	34
3 Segmentation of Global Market by Type	38
3.1 Market Overview by Type	38
3.2 Monoclonal Antibodies	40
3.3 Polyclonal Antibodies	41
3.4 Other Types	42
4 Segmentation of Global Market by Application	43
4.1 Market Overview by Application	43
4.2 Oncology Diagnosis	45
4.3 Hepatitis Diagnosis	46
4.4 Infectious Disease Diagnosis	47
4.5 Dengue Diagnostics	48
4.6 Tuberculosis Diagnostics	49
4.7 HIV Diagnostics	50
4.8 Other Applications	51
5 Segmentation of Global Market by End User	52
5.1 Market Overview by End User	52
5.2 Hospitals & Clinics	54
5.3 Diagnostic Laboratories	55
5.4 Other End Users	56
6 Segmentation of Global Market by Region	57
6.1 Geographic Market Overview 2020-2027	57
6.2 North America Market 2020-2027 by Country	61
6.2.1 Overview of North America Market	61
6.2.2 U.S.	64
6.2.3 Canada	67
6.2.4 Mexico	69
6.3 European Market 2020-2027 by Country	71
6.3.1 Overview of European Market	71
6.3.2 UK	74
6.3.3 France	76
6.3.4 Germany	78
6.3.5 Spain	80
6.3.6 Italy	82
6.3.7 Russia	84
6.3.8 Rest of European Market	86
6.4 Asia-Pacific Market 2020-2027 by Country	88
6.4.1 Overview of Asia-Pacific Market	88
6.4.2 China	91
6.4.3 Japan	93
6.4.4 India	96
6.4.5 Australia	98
6.4.6 South Korea	100
6.4.7 Rest of APAC Region	102
6.5 South America Market 2020-2027 by Country	104
6.5.1 Argentina	107
6.5.2 Brazil	109
6.5.3 Chile	111
6.5.4 Rest of South America Market	113
6.6 MEA Market 2020-2027 by Country	114
6.6.1 UAE	117
6.6.2 Saudi Arabia	119
6.6.3 South Africa	121
6.6.4 Other National Markets	123
7 Competitive Landscape	124
7.1 Overview of Key Vendors	124
7.2 New Product Launch, Partnership, Investment, and M&A	127
7.3 Company Profiles	128
Abbott Laboratories	128
Abcam plc	130
Agilent Technologies, Inc.	131
Aytu BioScience, Inc.	132
Becton, Dickinson and Company	133
Bio-Rad Laboratories, Inc.	134
Boehringer Ingelheim International GmbH	135
Creative Diagnostics	136
Enzo Life Sciences, Inc.	137
F. Hoffmann-La Roche AG	138
Merck KGaA	139
Polymun Scientific Immunbiologische Forschung GmbH	140
Sanofi S.A.	141
Sartorius AG	142
Thermo Fisher Scientific Inc.	143
RELATED REPORTS	144
List Of Tables

Table 1.  Snapshot of Global Diagnostic Specialty Antibodies Market in Balanced Perspective, 2020-2027	18
Table 2. Growth Rate of World GDP, 2020-2022	21
Table 3.  Main Product Trends and Market Opportunities in Global Diagnostic Specialty Antibodies Market	30
Table 4. Global Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	38
Table 5. Global Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	43
Table 6. Global Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	52
Table 7. Global Diagnostic Specialty Antibodies Market by Region, 2017-2027, $ mn	58
Table 8.  Leading National Diagnostic Specialty Antibodies Market, 2020 and 2027, $ mn	60
Table 9. North America Diagnostic Specialty Antibodies Market by Country, 2017-2027, $ mn	63
Table 10. U.S. Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	66
Table 11. U.S. Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	66
Table 12. U.S. Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	66
Table 13. Canada Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	68
Table 14. Canada Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	68
Table 15. Canada Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	68
Table 16. Mexico Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	70
Table 17. Mexico Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	70
Table 18. Mexico Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	70
Table 19. Europe Diagnostic Specialty Antibodies Market by Country, 2017-2027, $ mn	73
Table 20. UK Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	75
Table 21. UK Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	75
Table 22. UK Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	75
Table 23. France Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	77
Table 24. France Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	77
Table 25. France Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	77
Table 26. Germany Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	79
Table 27. Germany Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	79
Table 28. Germany Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	79
Table 29. Spain Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	81
Table 30. Spain Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	81
Table 31. Spain Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	81
Table 32. Italy Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	83
Table 33. Italy Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	83
Table 34. Italy Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	83
Table 35. Russia Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	85
Table 36. Russia Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	85
Table 37. Russia Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	85
Table 38. Diagnostic Specialty Antibodies Market in Rest of Europe by Country, 2017-2027, $ mn	87
Table 39. APAC Diagnostic Specialty Antibodies Market by Country, 2017-2027, $ mn	90
Table 40. China Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	92
Table 41. China Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	92
Table 42. China Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	92
Table 43. Japan Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	95
Table 44. Japan Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	95
Table 45. Japan Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	95
Table 46. India Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	97
Table 47. India Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	97
Table 48. India Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	97
Table 49. Australia Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	99
Table 50. Australia Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	99
Table 51. Australia Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	99
Table 52. South Korea Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	101
Table 53. South Korea Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	101
Table 54. South Korea Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	101
Table 55. Diagnostic Specialty Antibodies Market in Rest of APAC by Country/Region, 2017-2027, $ mn	103
Table 56. South America Diagnostic Specialty Antibodies Market by Country, 2017-2027, $ mn	106
Table 57. Argentina Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	108
Table 58. Argentina Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	108
Table 59. Argentina Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	108
Table 60. Brazil Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	110
Table 61. Brazil Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	110
Table 62. Brazil Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	110
Table 63. Chile Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	112
Table 64. Chile Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	112
Table 65. Chile Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	112
Table 66. MEA Diagnostic Specialty Antibodies Market by Country, 2017-2027, $ mn	116
Table 67. UAE Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	118
Table 68. UAE Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	118
Table 69. UAE Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	118
Table 70. Saudi Arabia Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	120
Table 71. Saudi Arabia Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	120
Table 72. Saudi Arabia Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	120
Table 73. South Africa Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn	122
Table 74. South Africa Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn	122
Table 75. South Africa Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn	122
Table 76. Abbott Laboratories: Company Snapshot	128
Table 77. Abbott Laboratories: Business Segmentation	128
Table 78. Abbott Laboratories: Product Portfolio	129
Table 79. Abbott Laboratories: Revenue, 2017-2019, $ mn	129
List Of Figures

Figure 1. Research Method Flow Chart	12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	15
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027	17
Figure 4. Global Diagnostic Specialty Antibodies Market, 2017-2027, $ mn	19
Figure 5. Impact of COVID-19 on Business	22
Figure 6. Primary Drivers and Impact Factors of Global Diagnostic Specialty Antibodies Market	24
Figure 7. Primary Restraints and Impact Factors of Global Diagnostic Specialty Antibodies Market	27
Figure 8. Investment Opportunity Analysis	31
Figure 9. Porter’s Fiver Forces Analysis of Global Diagnostic Specialty Antibodies Market	34
Figure 10. Breakdown of Global Diagnostic Specialty Antibodies Market by Type, 2020-2027, % of Revenue	38
Figure 11. Contribution to Global 2021-2027 Cumulative Revenue by Type, Value ($ mn) and Share (%)	39
Figure 12. Global Diagnostic Specialty Antibodies Market: Monoclonal Antibodies, 2017-2027, $ mn	40
Figure 13. Global Diagnostic Specialty Antibodies Market: Polyclonal Antibodies, 2017-2027, $ mn	41
Figure 14. Global Diagnostic Specialty Antibodies Market: Other Types, 2017-2027, $ mn	42
Figure 15. Breakdown of Global Diagnostic Specialty Antibodies Market by Application, 2020-2027, % of Revenue	43
Figure 16. Contribution to Global 2021-2027 Cumulative Revenue by Application, Value ($ mn) and Share (%)	44
Figure 17. Global Diagnostic Specialty Antibodies Market: Oncology Diagnosis, 2017-2027, $ mn	45
Figure 18. Global Diagnostic Specialty Antibodies Market: Hepatitis Diagnosis, 2017-2027, $ mn	46
Figure 19. Global Diagnostic Specialty Antibodies Market: Infectious Disease Diagnosis, 2017-2027, $ mn	47
Figure 20. Global Diagnostic Specialty Antibodies Market: Dengue Diagnostics, 2017-2027, $ mn	48
Figure 21. Global Diagnostic Specialty Antibodies Market: Tuberculosis Diagnostics, 2017-2027, $ mn	49
Figure 22. Global Diagnostic Specialty Antibodies Market: HIV Diagnostics, 2017-2027, $ mn	50
Figure 23. Global Diagnostic Specialty Antibodies Market: Other Applications, 2017-2027, $ mn	51
Figure 24. Breakdown of Global Diagnostic Specialty Antibodies Market by End User, 2020-2027, % of Revenue	52
Figure 25. Contribution to Global 2021-2027 Cumulative Revenue by End User, Value ($ mn) and Share (%)	53
Figure 26. Global Diagnostic Specialty Antibodies Market: Hospitals & Clinics, 2017-2027, $ mn	54
Figure 27. Global Diagnostic Specialty Antibodies Market: Diagnostic Laboratories, 2017-2027, $ mn	55
Figure 28. Global Diagnostic Specialty Antibodies Market: Other End Users, 2017-2027, $ mn	56
Figure 29.  Global Market Snapshot by Region	57
Figure 30.  Geographic Spread of Worldwide Diagnostic Specialty Antibodies Market, 2020-2027, % of Revenue	58
Figure 31. Contribution to Global 2021-2027 Cumulative Revenue by Region, Value ($ mn) and Share (%)	59
Figure 32.  North American Diagnostic Specialty Antibodies Market, 2017-2027, $ mn	62
Figure 33. Breakdown of North America Diagnostic Specialty Antibodies Market by Country, 2020 and 2027, % of Revenue	62
Figure 34. Contribution to North America 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)	63
Figure 35. U.S. Diagnostic Specialty Antibodies Market, 2017-2027, $ mn	65
Figure 36. Canada Diagnostic Specialty Antibodies Market, 2017-2027, $ mn	67
Figure 37.  Diagnostic Specialty Antibodies Market in Mexico, 2017-2027, $ mn	69
Figure 38.  European Diagnostic Specialty Antibodies Market, 2017-2027, $ mn	72
Figure 39. Breakdown of European Diagnostic Specialty Antibodies Market by Country, 2020 and 2027, % of Revenue	72
Figure 40. Contribution to Europe 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)	73
Figure 41.  Diagnostic Specialty Antibodies Market in UK, 2017-2027, $ mn	74
Figure 42.  Diagnostic Specialty Antibodies Market in France, 2017-2027, $ mn	76
Figure 43.  Diagnostic Specialty Antibodies Market in Germany, 2017-2027, $ mn	78
Figure 44.  Diagnostic Specialty Antibodies Market in Spain, 2017-2027, $ mn	80
Figure 45.  Diagnostic Specialty Antibodies Market in Italy, 2017-2027, $ mn	82
Figure 46.  Diagnostic Specialty Antibodies Market in Russia, 2017-2027, $ mn	84
Figure 47.  Diagnostic Specialty Antibodies Market in Rest of Europe, 2017-2027, $ mn	86
Figure 48. Asia-Pacific Diagnostic Specialty Antibodies Market, 2017-2027, $ mn	89
Figure 49. Breakdown of APAC Diagnostic Specialty Antibodies Market by Country, 2020 and 2027, % of Revenue	89
Figure 50. Contribution to APAC 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)	90
Figure 51.  Diagnostic Specialty Antibodies Market in China, 2017-2027, $ mn	91
Figure 52.  Diagnostic Specialty Antibodies Market in Japan, 2017-2027, $ mn	94
Figure 53.  Diagnostic Specialty Antibodies Market in India, 2017-2027, $ mn	96
Figure 54.  Diagnostic Specialty Antibodies Market in Australia, 2017-2027, $ mn	98
Figure 55.  Diagnostic Specialty Antibodies Market in South Korea, 2017-2027, $ mn	100
Figure 56.  Diagnostic Specialty Antibodies Market in Rest of APAC, 2017-2027, $ mn	102
Figure 57. South America Diagnostic Specialty Antibodies Market, 2017-2027, $ mn	105
Figure 58. Breakdown of South America Diagnostic Specialty Antibodies Market by Country, 2020 and 2027, % of Revenue	105
Figure 59. Contribution to South America 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)	106
Figure 60.  Diagnostic Specialty Antibodies Market in Argentina, 2017-2027, $ mn	107
Figure 61.  Diagnostic Specialty Antibodies Market in Brazil, 2017-2027, $ mn	109
Figure 62.  Diagnostic Specialty Antibodies Market in Chile, 2017-2027, $ mn	111
Figure 63.  Diagnostic Specialty Antibodies Market in Rest of South America, 2017-2027, $ mn	113
Figure 64. Diagnostic Specialty Antibodies Market in Middle East and Africa (MEA), 2017-2027, $ mn	115
Figure 65. Breakdown of MEA Diagnostic Specialty Antibodies Market by Country, 2020 and 2027, % of Revenue	115
Figure 66. Contribution to MEA 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)	116
Figure 67.  Diagnostic Specialty Antibodies Market in UAE, 2017-2027, $ mn	117
Figure 68.  Diagnostic Specialty Antibodies Market in Saudi Arabia, 2017-2027, $ mn	119
Figure 69.  Diagnostic Specialty Antibodies Market in South Africa, 2017-2027, $ mn	121
Figure 70. Growth Stage of Global Diagnostic Specialty Antibodies Industry over the Forecast Period	124
Key Players (this may not be a complete list and extra companies can be added upon request): 
Abbott Laboratories
Abcam plc
Agilent Technologies, Inc.
Aytu BioScience, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Boehringer Ingelheim International GmbH
Creative Diagnostics
Enzo Life Sciences, Inc.
F. Hoffmann-La Roche AG
Merck KGaA
Polymun Scientific Immunbiologische Forschung GmbH
Sanofi S.A.
Sartorius AG
Thermo Fisher Scientific Inc.
 (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)